OptiNose Cash Conversion Cycle 2011-2026 | OPTN

Annual Cash Conversion Cycle OptiNose

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
314	323	291	346	136	136	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
346	136	258

Quarterly Cash Conversion Cycle OptiNose

2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
667	-	493	494	571	-	188	150	362	-	187	211	351	-	406	370	375	-	138	208	239	-	-7.34	-8.99	-4	-	14.8	21.5	-866	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
667	-866	207

Cash Conversion Cycle of other stocks in the Drug manufacturers industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	-38	-	7.5 %	$ 6.35 M	USA
Alimera Sciences ALIM	-128	-	-	$ 142 M	USA
Aerie Pharmaceuticals AERI	460	-	-	$ 754 M	USA
Agile Therapeutics AGRX	-206	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	-224	-	0.86 %	$ 117 M	USA
Canopy Growth Corporation CGC	177	$ 0.95	-2.04 %	$ 102 M	Canada
Aurora Cannabis ACB	1.45 K	$ 3.29	-0.61 %	$ 86.3 M	Canada
China Pharma Holdings CPHI	164	$ 0.63	-	$ 11 M	China
Catalent CTLT	110	-	-	$ 11.5 B	USA
Athenex ATNX	137	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	192	-	-	$ 2.06 B	France
Cronos Group CRON	213	$ 2.51	-0.31 %	$ 1.31 B	Canada
DURECT Corporation DRRX	41.4	-	-	$ 50.1 M	USA
Emergent BioSolutions EBS	181	$ 7.96	-1.12 %	$ 408 M	USA
Endo International plc ENDP	141	-	-	$ 28.9 M	Irlanda
Pacira BioSciences PCRX	209	$ 22.63	-0.09 %	$ 1.05 B	USA
Evoke Pharma EVOK	45.7	-	-	$ 36.6 M	USA
HEXO Corp. HEXO	775	-	2.45 %	$ 38.1 M	Canada
Cumberland Pharmaceuticals CPIX	-161	$ 3.15	3.28 %	$ 44.3 M	USA
Rockwell Medical RMTI	45	$ 1.05	2.45 %	$ 24.5 M	USA
Bausch Health Companies BHC	78.9	$ 4.98	-2.35 %	$ 1.82 B	Canada
Sonoma Pharmaceuticals SNOA	150	$ 2.39	-6.13 %	$ 2.97 M	USA
Harrow Health HROW	18.3	$ 35.27	3.74 %	$ 1.3 B	USA
Tilray TLRY	169	$ 6.43	-0.31 %	$ 3.97 B	Canada
Evolus EOLS	74.8	$ 4.61	-1.6 %	$ 297 M	USA
Veru VERU	6.7	$ 2.3	-	$ 310 M	USA
Eagle Pharmaceuticals EGRX	139	-	-39.89 %	$ 27.7 M	USA
Viatris VTRS	155	$ 13.43	1.02 %	$ 16.1 B	USA
OrganiGram Holdings OGI	2.92 K	$ 1.36	-	$ 402 M	Canada
PetIQ PETQ	53.8	-	1.64 %	$ 400 M	USA
PLx Pharma PLXP	111	-	-27.8 %	$ 2.56 M	USA
ProPhase Labs PRPH	96	-	-	$ 5.07 M	USA
Jupiter Wellness JUPW	-21.1	-	-	$ 33.6 M	USA
Radius Health RDUS	-53.5	-	-	$ 1.42 B	USA
Lannett Company LCI	173	-	1.15 %	$ 7.11 M	USA
SCYNEXIS SCYX	106	$ 0.88	0.79 %	$ 43.9 M	USA
TherapeuticsMD TXMD	-723	$ 2.35	1.73 %	$ 24.5 M	USA
cbdMD YCBD	92	$ 0.78	2.25 %	$ 3.36 M	USA
Organogenesis Holdings ORGO	64.5	$ 2.42	-2.23 %	$ 319 M	USA
Perrigo Company plc PRGO	137	$ 9.64	0.68 %	$ 1.34 B	USA
Assertio Holdings ASRT	467	$ 15.21	8.64 %	$ 97.4 M	USA
Recro Pharma REPH	105	-	-4.76 %	$ 65.3 M	USA